Moleculin Biotech, Inc. - stock earnings
MBRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -5.6 million USD | ? USD |
| 2023Q2 | -6.0 million USD | ? USD |
| 2023Q1 | -7.4 million USD | ? USD |
| 2022Q4 | -5.6 million USD | ? USD |
| 2022Q3 | -8.6 million USD | ? USD |
| 2022Q2 | -6.7 million USD | ? USD |
| 2022Q1 | -6.7 million USD | ? USD |
| 2021Q4 | -2.8 million USD | ? USD |
| 2021Q3 | -4.4 million USD | 41 USD |
| 2021Q2 | -4.2 million USD | 44 USD |
| 2021Q1 | -4.4 million USD | 44 USD |
| 2020Q4 | -2.6 million USD | ? USD |
| 2020Q3 | -3.4 million USD | ? USD |
| 2020Q2 | -10.1 million USD | ? USD |
| 2020Q1 | -1.2 million USD | ? USD |
| 2019Q4 | -3.8 million USD | ? USD |
| 2019Q3 | -4.1 million USD | ? USD |
| 2019Q2 | -1.2 million USD | ? USD |
| 2019Q1 | -4.0 million USD | ? USD |
| 2018Q4 | -2.8 million USD | ? USD |
| 2018Q3 | -2.0 million USD | ? USD |
| 2018Q2 | -5.1 million USD | ? USD |
| 2018Q1 | -1.9 million USD | ? USD |
| 2017Q4 | -3.2 million USD | ? USD |
| 2017Q3 | -2.9 million USD | 9000 USD |
| 2017Q2 | -3.4 million USD | ? USD |
| 2017Q1 | -1.4 million USD | ? USD |
| 2016Q4 | -1.4 million USD | ? USD |
| 2016Q3 | -1.4 million USD | ? USD |
| 2016Q2 | -995616 USD | ? USD |
| 2016Q1 | -332241 USD | ? USD |
| 2015Q4 | -1.8 million USD | ? USD |
MBRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -26.3 million USD | ? USD |
| 2022 | -27.4 million USD | ? USD |
| 2021 | -8.9 million USD | ? USD |
| 2020 | -15.0 million USD | ? USD |
| 2019 | -13.2 million USD | ? USD |
| 2018 | -11.9 million USD | ? USD |
| 2017 | -9.8 million USD | 9000 USD |
| 2016 | -3.9 million USD | ? USD |
| 2015 | -365810 USD | ? USD |
MBRX
Price: $5.02
52 week price:
Earnings Per Share: -15.15 USD
P/E Ratio: -0.56
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 14187
Ebitda: -2.9 millionMarket Capitalization: 11.8 million